<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Methoxyflurane - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../sickbay-shared.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Methoxyflurane</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Analgesia / Anti-inflammatory</div>
      <h1>Methoxyflurane</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Methoxyflurane 3mL Inhaler (Penthrox)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Acute pain (trauma, procedures)</strong>
            <ul>
              <li>Inhale intermittently as needed for pain relief; patient self-administers via Penthrox inhaler</li>
              <li>Maximum single use: 3 mL (one inhaler) over one treatment session</li>
              <li>Maximum total dose: 6 mL per day, 15 mL per week (to reduce nephrotoxicity risk)</li>
              <li>Onset of analgesia: typically 6–10 inhalations (~2–3 minutes)</li>
              <li>Duration: analgesic effect lasts ~20–30 minutes after stopping inhalation</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Short-term relief of moderate to severe acute pain in conscious adults (e.g., trauma, burns, procedures, acute MSK injury)</li>
          <li>Particularly useful when IV access is not available or opioids are not appropriate/available</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li><strong>Contraindicated:</strong> significant renal impairment; clinically significant cardiovascular or respiratory instability; impaired consciousness; hypersensitivity to fluorinated anesthetics; malignant hyperthermia risk</li>
          <li>Nephrotoxicity: avoid exceeding maximum doses; do not use repeatedly over short periods</li>
          <li>CNS depression/sedation: patient must be able to self-administer and follow instructions; caution with concurrent CNS depressants/opioids</li>
          <li>Hepatotoxicity risk (rare): avoid in significant liver disease</li>
          <li>Pregnancy/lactation: avoid unless clearly needed (limited data)</li>
          <li>Use in well-ventilated area; avoid use in confined spaces (occupational exposure concern for bystanders)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Dizziness, drowsiness, headache</li>
          <li>Nausea (uncommon at analgesic doses)</li>
          <li>Euphoria, dysphoria (dose-related)</li>
          <li>Nephrotoxicity (dose-related; risk increases with cumulative dose)</li>
          <li>Hepatotoxicity (rare)</li>
          <li>Cough, throat irritation</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Patient self-administers using the Penthrox inhaler device (green whistle)</li>
          <li>Insert 3 mL vial into inhaler chamber as per manufacturer instructions</li>
          <li>Patient inhales through mouthpiece intermittently as needed for pain</li>
          <li>Instruct patient: "Take slow, deep breaths through the mouthpiece when you feel pain. Stop when pain is controlled."</li>
          <li>Use the dilutor (adjustable valve) for less intense dosing if needed</li>
          <li>Activated charcoal chamber filter reduces environmental exposure</li>
          <li>Monitor patient continuously; they must remain conscious and able to self-administer</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Pain relief (self-reported pain score)</li>
          <li>Level of consciousness and respiratory effort (patient must remain alert enough to self-administer)</li>
          <li>Sedation/dizziness (fall risk; keep patient seated/lying down)</li>
          <li>Vital signs (HR, BP, RR, SpO2 if available)</li>
          <li>Do not exceed maximum doses (6 mL/day, 15 mL/week) to reduce nephrotoxicity risk</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Excellent option for acute pain when IV access is difficult or opioids are not immediately available</li>
          <li>Patient must be conscious, cooperative, and able to follow instructions (not appropriate for severely altered patients)</li>
          <li>Use in well-ventilated areas when possible; minimize bystander exposure in confined spaces</li>
          <li>Document total dose used (each 3 mL inhaler) to avoid exceeding weekly limits if repeated use</li>
          <li>If pain persists or worsens, reassess for underlying injury requiring definitive care/evacuation</li>
          <li>Not a substitute for definitive analgesia in prolonged pain; consider transition to oral/parenteral analgesia as appropriate</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (Penthrox - methoxyflurane): <a href="https://pdf.hres.ca/dpd_pm/00055534.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00055534.PDF</a></li>
          <li>Penthrox (methoxyflurane) manufacturer instructions: <a href="https://www.penthrox.ca/" target="_blank" rel="noopener">https://www.penthrox.ca/</a></li>
          <li>Medscape drug reference (methoxyflurane): <a href="https://reference.medscape.com/drug/penthrox-methoxyflurane-1000210" target="_blank" rel="noopener">https://reference.medscape.com/drug/penthrox-methoxyflurane-1000210</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
